UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 285 filers reported holding ROYALTY PHARMA PLC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.6%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q2 2024$73,765,515
+30.3%
2,797,327
+50.1%
0.02%
+5.0%
Q1 2024$56,601,265
+35.8%
1,863,723
+25.6%
0.02%
+25.0%
Q4 2023$41,691,318
+14.1%
1,484,205
+10.2%
0.02%0.0%
Q3 2023$36,545,666
-12.3%
1,346,561
+16.4%
0.02%
-20.0%
Q2 2023$41,686,7110.0%1,157,0000.0%0.02%0.0%
Q1 2023$41,686,711
-3.3%
1,157,000
+6.1%
0.02%
-13.0%
Q4 2022$43,104,505
-99.9%
1,090,701
+6.0%
0.02%0.0%
Q3 2022$41,361,573,000
+5.0%
1,029,407
+9.9%
0.02%
+9.5%
Q2 2022$39,375,337,000
+7.7%
936,616
-0.2%
0.02%
+31.2%
Q1 2022$36,559,323,000
+0.2%
938,381
+2.5%
0.02%
+14.3%
Q4 2021$36,489,928,000
+71.1%
915,682
+55.2%
0.01%
+55.6%
Q3 2021$21,327,624,000
-9.3%
590,139
+2.9%
0.01%
-10.0%
Q2 2021$23,505,102,000
+4.0%
573,435
+10.7%
0.01%0.0%
Q1 2021$22,593,152,000517,9540.01%
Other shareholders
ROYALTY PHARMA PLC shareholders Q2 2022
NameSharesValueWeighting ↓
SIGULER GUFF ADVISERS, LLC 6,761,970$263,446,00059.92%
Memorial Sloan Kettering Cancer Center 1,128,255$43,957,00050.90%
Vantage Consulting Group Inc 2,727,854$106,277,00041.47%
Indie Asset Partners, LLC 756,874$29,488,00022.15%
Overbrook Management Corp 723,250$28,178,0006.25%
Brown University 621,759$24,224,0005.93%
Geo Capital Gestora de Recursos Ltd 200,692$8,527,0003.82%
Lagoda Investment Management, L.P. 141,560$5,515,0002.97%
Greytown Advisors Inc. 131,143$5,109,0002.47%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,025,610$78,918,0002.41%
View complete list of ROYALTY PHARMA PLC shareholders